Tower Research Capital LLC (Trc) Rigel Pharmaceuticals Inc Transaction History

Tower Research Capital LLC (Trc)

$3.68 Billion
Q3 2024

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	SELL	$1.12 - $1.57 $9,713 - $13,616	-8,673 Reduced 87.37%	1,254 $1,000
Q4 2023 Feb 13, 2024	BUY	$0.72 - $1.56 $41 - $90	58 Added 0.59%	9,927 $14,000
Q3 2023 Nov 14, 2023	SELL	$1.07 - $1.39 $12,652 - $16,436	-11,825 Reduced 54.51%	9,869 $10,000
Q2 2023 Aug 14, 2023	BUY	$1.12 - $1.82 $10,655 - $17,315	9,514 Added 78.11%	21,694 $27,000
Q1 2023 May 09, 2023	SELL	$1.25 - $2.0 $5,010 - $8,016	-4,008 Reduced 24.76%	12,180 $16,000
Q4 2022 Feb 10, 2023	SELL	$0.67 - $11.9 $11,182 - $198,611	-16,690 Reduced 50.76%	16,188 $24,000
Q3 2022 Nov 10, 2022	SELL	$1.1 - $12.2 $84,772 - $940,205	-77,066 Reduced 70.1%	32,878 $39,000
Q2 2022 Aug 15, 2022	BUY	$0.67 - $3.19 $55,899 - $266,148	83,432 Added 314.7%	109,944 $124,000
Q1 2022 May 12, 2022	SELL	$2.22 - $3.45 $77,082 - $119,790	-34,722 Reduced 56.7%	26,512 $80,000
Q4 2021 Feb 14, 2022	BUY	$2.36 - $3.57 $65,473 - $99,042	27,743 Added 82.84%	61,234 $162,000
Q3 2021 Nov 15, 2021	BUY	$3.5 - $4.5 $72,278 - $92,929	20,651 Added 160.83%	33,491 $121,000
Q2 2021 Aug 16, 2021	SELL	$3.09 - $4.54 $13,339 - $19,599	-4,317 Reduced 25.16%	12,840 $55,000
Q1 2021 May 17, 2021	BUY	$3.35 - $4.93 $21,084 - $31,029	6,294 Added 57.94%	17,157 $58,000
Q4 2020 Feb 16, 2021	SELL	$2.35 - $3.74 $509,846 - $811,415	-216,956 Reduced 95.23%	10,863 $38,000
Q3 2020 Nov 16, 2020	BUY	$1.78 - $4.13 $341,017 - $791,237	191,583 Added 528.71%	227,819 $547,000
Q2 2020 Aug 13, 2020	BUY	$1.41 - $2.05 $51,092 - $74,283	36,236 New	36,236 $66,000
Q1 2020 May 15, 2020	SELL	$1.27 - $3.0 $96 - $228	-76 Closed	0 $0
Q4 2019 Feb 07, 2020	SELL	$1.6 - $2.43 $2,060 - $3,129	-1,288 Reduced 94.43%	76 $0
Q3 2019 Nov 05, 2019	BUY	$1.63 - $2.62 $2,104 - $3,382	1,291 Added 1768.49%	1,364 $3,000
Q2 2019 Aug 13, 2019	SELL	$2.02 - $2.61 $135 - $174	-67 Reduced 47.86%	73 $0
Q1 2019 May 14, 2019	BUY	$2.0 - $2.65 $280 - $371	140 New	140 $0
Q3 2018 Nov 13, 2018	SELL	$2.6 - $3.59 $50,918 - $70,306	-19,584 Closed	0 $0
Q2 2018 Aug 15, 2018	BUY	$2.83 - $4.11 $29,785 - $43,257	10,525 Added 116.18%	19,584 $56,000
Q1 2018 May 15, 2018	BUY	$3.54 - $4.54 $32,068 - $41,127	9,059 New	9,059 $32,000
Q4 2017 Feb 09, 2018	SELL	$3.23 - $4.3 $62,607 - $83,346	-19,383 Closed	0 $0
Q3 2017 Nov 14, 2017	BUY	$2.18 - $2.57 $42,254 - $49,814	19,383	19,383 $49,000

Others Institutions Holding RIGL

# of Institutions

Shares Held

334K

Call Options Held

Put Options Held

View Full List

About RIGEL PHARMACEUTICALS INC

Ticker RIGL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 172,836,000
Market Cap $2.96B
Description
Rigel Pharmaceuticals, Inc., a biotechnology company, discovers and develops small molecule drugs to treat hematologic disorders, cancer, and rare immune diseases. The company offers Tavalisse, an oral spleen tyrosine kinase inhibitor for the treatment of adult patients with chronic immune thrombocytopenia. It also develops Fostamatinib that is ...

More about RIGL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Tower Research Capital LLC (Trc), based on Form 13F filings with the SEC.

News

Stay updated on Tower Research Capital LLC (Trc) with notifications on news.

Account